Jennifer A. Chan mainly investigates Cancer research, Internal medicine, Gene expression profiling, Bioinformatics and Cancer. Her studies in Cancer research integrate themes in fields like Carcinogenesis, CDKN2A Deletion, Kinase and Follow up studies. Jennifer A. Chan has researched Internal medicine in several fields, including Gastroenterology, Endocrinology and Oncology.
Her work deals with themes such as DNA methylation, Glioma, Hepatocellular carcinoma, Computational biology and Polymerase chain reaction, which intersect with Gene expression profiling. Her Bioinformatics study combines topics in areas such as Structural variation and Wnt signaling pathway. Her work carried out in the field of Cancer brings together such families of science as Chromothripsis, Medulloblastoma and Transcription factor.
Jennifer A. Chan focuses on Internal medicine, Cancer research, Oncology, Neuroendocrine tumors and Cancer. The various areas that Jennifer A. Chan examines in her Internal medicine study include Gastroenterology and Surgery. Her Cancer research research is multidisciplinary, incorporating perspectives in Mutation, microRNA and Stem cell.
The Oncology study combines topics in areas such as Prospective cohort study, Clinical trial, Cohort, Pathology and Bevacizumab. Her Neuroendocrine tumors research is multidisciplinary, incorporating elements of Carcinoid syndrome, Octreotide, Pharmacology and Disease. Her biological study spans a wide range of topics, including Chromatin, Epigenomics and Epigenetics.
Jennifer A. Chan mainly focuses on Cell biology, Cancer, Chromatin, Neuroendocrine tumors and Internal medicine. Her work on Neural stem cell as part of general Cell biology study is frequently linked to Parkin, therefore connecting diverse disciplines of science. Her Cancer study combines topics from a wide range of disciplines, such as Developmental psychology and Cause of death.
Jennifer A. Chan interconnects Stage and Oncology in the investigation of issues within Neuroendocrine tumors. Her Internal medicine study frequently links to other fields, such as Gastroenterology. Her work investigates the relationship between Histone and topics such as Function that intersect with problems in Cancer research.
The scientist’s investigation covers issues in Cell biology, Neuroendocrine tumors, Internal medicine, Parkin and Oxidative phosphorylation. Her Cell biology study incorporates themes from Transcription factor, PAX6, Chromatin, Regulation of gene expression and Gene silencing. Jennifer A. Chan has included themes like Peptide receptor and Radionuclide therapy in her Neuroendocrine tumors study.
Many of her studies on Internal medicine involve topics that are commonly interrelated, such as Gastroenterology. Her study in Gastroenterology is interdisciplinary in nature, drawing from both Tolerability, Adverse effect, Clinical endpoint and Phases of clinical research. Her Oxidative phosphorylation research is multidisciplinary, relying on both Midbrain, Substantia nigra, Neuroprotection, Dopamine and Human brain.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells.
Jennifer A. Chan;Anna M. Krichevsky;Kenneth S. Kosik.
Cancer Research (2005)
Gene regulation and DNA damage in the ageing human brain.
Tao Lu;Ying Pan;Shyan Yuan Kao;Cheng Li.
Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
Yujin Hoshida;Augusto Villanueva;Masahiro Kobayashi;Judit Peix.
Physical Activity and Survival After Colorectal Cancer Diagnosis
Jeffrey A. Meyerhardt;Edward L. Giovannucci;Michelle D. Holmes;Andrew T. Chan.
Journal of Clinical Oncology (2006)
Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma.
Yujin Hoshida;Sebastian M.B. Nijman;Sebastian M.B. Nijman;Masahiro Kobayashi;Jennifer A. Chan;Jennifer A. Chan.
Cancer Research (2009)
Subgroup-specific structural variation across 1,000 medulloblastoma genomes
Paul A. Northcott;Paul A. Northcott;David J.H. Shih;John Peacock;Livia Garzia.
The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer.
Mark M. Pomerantz;Nasim Ahmadiyeh;Nasim Ahmadiyeh;Li Jia;Paula Herman.
Nature Genetics (2009)
Intertumoral Heterogeneity within Medulloblastoma Subgroups
Florence M.G. Cavalli;Marc Remke;Marc Remke;Marc Remke;Ladislav Rampasek;John Peacock.
Cancer Cell (2017)
CDK8 is a colorectal cancer oncogene that regulates β-catenin activity
Ron Firestein;Adam Bass;So Young Kim;Ian Frederick Dunn.
A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors
Joshua B. Rubin;Andrew L. Kung;Robyn S. Klein;Jennifer A. Chan.
Proceedings of the National Academy of Sciences of the United States of America (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: